Abstract
Goal Our global aim is to decrease the number of acid suppressants used in the Rainbow Babies and Children’s NICU. The specific aim is to implement guidelines on appropriate use of acid-suppressing medications to decrease use by 50% in patients without indications by March 2019. Introduction Reflux is a physiologic occurrence in infants; it is particularly more prevalent in preterm babies. Previously, histamine-2 receptor antagonists (H2As) or proton pump inhibitors (PPIs) have been used for symptomatic reflux, apnea/bradycardia/desaturations, or irritability. Recent studies have shown, …
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have